Computed tomography colonography, also known as virtual colonoscopy.


June 3, 2010 - Positron emission tomography (PET) combined with computed tomography colonography (CTC) may provide a suitable alternative for detecting polyps and cancer in the colon and does not require sedation or bowel preparation, according to a study published in the June issue of The Journal of Nuclear Medicine.

Authors of the study, “Nonlaxative PET/CT Colonography: Feasibility, Acceptability, and Pilot Performance in Patients at Higher Risk of Colonic Neoplasia,” researched the effectiveness of using a combination of CTC, an imaging technique that is less invasive alternative to the standard colonoscopy test, and PET scans without any bowel preparation to detect significant abnormalities in the colon. The current study is the largest to date investigating combined PET CTC in patients without any bowel preparation.

Fifty-six patients agreed to undergo a one-hour CTC and PET scan without the use of laxatives two weeks before their scheduled colonoscopy. Patients then completed a questionnaire to see how they tolerated the tests and which one they preferred.

The colonoscopy results were then compared with the CTC scan on its own and with the CTC and PET scans combined. The study found that the combined PET CTC scans detected all the important larger polyps found by the invasive colonoscopy technique. In addition, most patients found the combined scan technique more comfortable and preferred it to colonoscopy.

“The work has shown that combined PET CTC is technically feasible, well tolerated by patients and capable of achieving high diagnostic accuracy,” said Stuart A. Taylor, M.D., University College London, and lead researcher of the study. “This test would be mainly used in patients less able to tolerate invasive investigations or the preparation required if physicians want to exclude any major pathology in the colon and abdomen.”

Reference: Taylor, S., Manpanzure, L., et al. “Nonlaxative PET/CT Colonography: Feasibility, Acceptability, and Pilot Performance in Patients at Higher Risk of Colonic Neoplasia.” The Journal of Nuclear Medicine. June 2010.

For more information: www.snm.org


Related Content

News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

March 28, 2024 — RefleXion Medical, Inc., a therapeutic oncology company, and Limbus AI, Inc., a provider of software ...

Time March 28, 2024
arrow
News | Artificial Intelligence

March 18, 2024 — RamSoft, a global leader in novel cloud-based RIS/PACS radiology solutions for imaging centers and ...

Time March 18, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
News | Radiology Imaging

March 5, 2024 — Life Guard Imaging, a pioneering leader in preventative imaging services, is thrilled to announce its ...

Time March 05, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | Artificial Intelligence

February 27, 2024 — Median Technologies announced that the Company will be participating and speaking at the premier ...

Time February 27, 2024
arrow
News | X-Ray

February 26, 2024 — AIxSCAN, Inc. began clinical trials in late 2023. The AIxSCAN, Inc. team is very pleased with the ...

Time February 26, 2024
arrow
Subscribe Now